Stocktoria
REGENTIS BIOMATERIALS LTD. RGNT
NYSE American · XASE · stock
REGENTIS BIOMATERIALS LTD. (RGNT) earns a Piotroski F-score of 1/9 (weak financial health). It does not currently pay a dividend.
Chart by TradingView
1/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Return on equity-287.7%
Piotroski F breakdown · 1/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
FAQ
Is RGNT financially healthy?
REGENTIS BIOMATERIALS LTD.'s Piotroski F-score is 1/9 (8–9 is excellent, 0–3 weak).
Does RGNT pay a dividend?
No, REGENTIS BIOMATERIALS LTD. does not currently pay a dividend.
How profitable is RGNT?
In FY2025, REGENTIS BIOMATERIALS LTD. had a return on equity of -287.7%.
Source: SEC EDGAR filings · CIK 0001912966 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.